Group 1 - The stock of Danna Biotechnology (920009) experienced a decline of 7.29% with a turnover rate of 26.88% and a trading volume of 177 million yuan, indicating significant market activity [2] - Institutional investors net sold 7.0494 million yuan, while brokerage seats collectively net bought 2.5829 million yuan, reflecting mixed investor sentiment [2] - The stock has appeared on the trading leaderboard nine times in the past six months, with an average price increase of 0.15% the day after being listed and an average increase of 0.28% over the following five days [2] Group 2 - The top five brokerage seats accounted for a total transaction volume of 51.7833 million yuan, with buying transactions amounting to 23.6584 million yuan and selling transactions totaling 28.1249 million yuan, resulting in a net sell of 4.4665 million yuan [2] - Specific trading details show that the leading buying brokerage was Guangfa Securities with a purchase of 10.2313 million yuan, while the top selling entity was an institutional seat with a sell amount of 78.987 million yuan [2] - The trading data indicates that the stock's volatility was notable, with a price fluctuation of 10.10% during the trading day [2]
丹娜生物11月18日龙虎榜数据